Y-mAbs Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/13/2025

Shares

308,130

Value ($000)

1,390

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/13/2025	1,390	0.0%	308,130	6/30/2025
2025 Q1	5/13/2025	1,453	0.0%	327,901	3/31/2025
2024 Q4	2/14/2025	2,813	0.0%	359,223	12/31/2024
2024 Q3	11/13/2024	4,435	0.0%	337,287	9/30/2024
2024 Q2	8/14/2024	3,839	0.0%	317,805	6/30/2024
2024 Q1	5/14/2024	5,231	0.0%	321,715	3/31/2024
2023 Q4	2/13/2024	2,219	0.0%	325,439	12/31/2023
2023 Q3	11/13/2023	1,761	0.0%	323,187	9/30/2023
2023 Q2	8/11/2023	2,231	0.0%	328,522	6/30/2023
2023 Q1	5/15/2023	1,515	0.0%	302,329	3/31/2023
2022 Q4	2/13/2023	1,564	0.0%	320,411	12/31/2022
2022 Q3	11/14/2022	4,745	0.0%	329,023	9/30/2022
2022 Q2	8/12/2022	5,039	0.0%	333,098	6/30/2022
2022 Q1	5/13/2022	3,888	0.0%	327,253	3/31/2022
2021 Q4	2/8/2022	5,576	0.0%	343,987	12/31/2021
2021 Q3	11/15/2021	9,904	0.0%	347,034	9/30/2021
2021 Q2	8/13/2021	11,709	0.0%	346,406	6/30/2021
2021 Q1	5/12/2021	10,457	0.0%	345,801	3/31/2021
2020 Q4	2/11/2021	17,483	0.0%	353,099	12/31/2020
2020 Q3	11/16/2020	14,365	0.0%	374,196	9/30/2020
2020 Q2	8/14/2020	16,384	0.0%	379,256	6/30/2020
2020 Q1	5/14/2020	7,738	0.0%	296,486	3/31/2020
2019 Q4	2/14/2020	9,029	0.0%	288,898	12/31/2019